Attenuation of Free Fatty Acid (FFA)-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol is Linked to Activation of AMPK and Inhibition of mTOR and p70 S6K

Int J Mol Sci. 2020 Jul 11;21(14):4900. doi: 10.3390/ijms21144900.

Abstract

Insulin resistance, a main characteristic of type 2 diabetes mellitus (T2DM), is linked to obesity and excessive levels of plasma free fatty acids (FFA). Studies indicated that significantly elevated levels of FFAs lead to skeletal muscle insulin resistance, by dysregulating the steps in the insulin signaling cascade. The polyphenol resveratrol (RSV) was shown to have antidiabetic properties but the exact mechanism(s) involved are not clearly understood. In the present study, we examined the effect of RSV on FFA-induced insulin resistance in skeletal muscle cells in vitro and investigated the mechanisms involved. Parental and GLUT4myc-overexpressing L6 rat skeletal myotubes were used. [3H]2-deoxyglucose (2DG) uptake was measured, and total and phosphorylated levels of specific proteins were examined by immunoblotting. Exposure of L6 cells to FFA palmitate decreased the insulin-stimulated glucose uptake, indicating insulin resistance. Palmitate increased ser307 (131% ± 1.84% of control, p < 0.001) and ser636/639 (148% ± 10.1% of control, p < 0.01) phosphorylation of IRS-1, and increased the phosphorylation levels of mTOR (174% ± 15.4% of control, p < 0.01) and p70 S6K (162% ± 20.2% of control, p < 0.05). Treatment with RSV completely abolished these palmitate-induced responses. In addition, RSV increased the activation of AMPK and restored the insulin-mediated increase in (a) plasma membrane GLUT4 glucose transporter levels and (b) glucose uptake. These data suggest that RSV has the potential to counteract the FFA-induced muscle insulin resistance.

Keywords: AMPK; Akt; GLUT4; IRS-1; free fatty acid; insulin resistance; mTOR; p70 S6K; palmitate; resveratrol.

MeSH terms

  • Adenylate Kinase / physiology*
  • Animals
  • Cell Line
  • Fatty Acids, Nonesterified / toxicity*
  • Glucose / metabolism
  • Glucose Transporter Type 4 / metabolism
  • Humans
  • Insulin Receptor Substrate Proteins / metabolism
  • Insulin Resistance / physiology*
  • Muscle Cells / drug effects
  • Muscle Cells / metabolism
  • Muscle, Skeletal / drug effects*
  • Muscle, Skeletal / metabolism
  • Palmitates / pharmacology
  • Palmitates / toxicity
  • Phosphorylation
  • Protein Processing, Post-Translational / drug effects
  • Protein Transport / drug effects
  • Rats
  • Resveratrol / pharmacology*
  • Ribosomal Protein S6 Kinases, 70-kDa / physiology*
  • Signal Transduction / drug effects
  • TOR Serine-Threonine Kinases / physiology*

Substances

  • Fatty Acids, Nonesterified
  • Glucose Transporter Type 4
  • Insulin Receptor Substrate Proteins
  • Irs1 protein, rat
  • Palmitates
  • Slc2a4 protein, rat
  • MTOR protein, human
  • Ribosomal Protein S6 Kinases, 70-kDa
  • TOR Serine-Threonine Kinases
  • Adenylate Kinase
  • Glucose
  • Resveratrol